Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引：0

作者：

Muddu, V. ^{[1
]}

Shah, A. ^{[2
]}

Raj, A. ^{[3
]}

Bahl, A. ^{[4
]}

Thirumalairaj, R. ^{[5
]}

Ghosh, J. ^{[6
]}

Ostwal, V. ^{[2
]}

Rajappa, S. ^{[7
]}

Vora, A. ^{[8
]}

Lavingia, V. ^{[9
]}

Sharma, A. ^{[10
]}

Khan, A. ^{[1
]}

Rohatgi, N. ^{[4
]}

Mahajan, M. ^{[11
]}

Chandrakanth, M. ^{[6
]}

Ramaswamy, A. ^{[12
]}

机构：

[1] AIG Hosp, Hyderabad, India

[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India

[3] Sarvodaya Hosp, Faridabad, India

[4] Fortis Canc Inst, Gurgaon, India

[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India

[6] Tata Med Ctr, Kolkata, India

[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India

[8] HOPE Oncol Care Clin, New Delhi, India

[9] HCG Canc Ctr, Ahmadabad, Gujarat, India

[10] All India Inst Med Sci, New Delhi, India

[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India

[12] Tata Mem Hosp, Mumbai, Maharashtra, India

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-209

引用

页码：S90 / S90

页数：1

共 50 条

[1] Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India
Muddu, Vamshi Krishna
Shah, Anjali
John, Anupa
Raj, Abhishek
Bahl, Ankur
Rajappa, Senthil J.
Raja, Thirumalairaj
Ghosh, Joydeep
Lavingia, Viraj
Vora, Amish
Bhargava, Prabhat
Ramaswamy, Anant
Khan, Arif
Sharma, Atul
Trikha, Mehak
Dhanawat, Aditya
Bonda, Avinash
Siripurapu, Indraja
Mahajan, Manoj
Rohatgi, Nitesh
Chandrakant, Mosale Venkatesha
Gujarathi, Himanshu
Vora, Manan
Ankathi, Sumankumar
Ostwal, Vikas S.
JCO GLOBAL ONCOLOGY, 2024, 10
[2] Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer
Huang, Wen-Kuan
Tang, Yan-Jei
Wu, Chiao-En
Hou, Ming-Mo
Hsu, Hung-Chih
Su, Po-Jung
Chiang, Nai-Jung
Chen, San-Chi
Yeh, Chun-Nan
Chen, Jen-Shi
Chen, Ming-Huang
Hsieh, Chia-Hsun
Chou, Wen-Chi
ONCOLOGIST, 2024,
[3] Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Alexander Olkus
Aurelie Tomczak
Anne Katrin Berger
Conrad Rauber
Philip Puchas
Cyrill Wehling
Thomas Longerich
Arianeb Mehrabi
De-Hua Chang
Jakob Liermann
Sophia Schäfer
Jan Pfeiffenberger
Dirk Jäger
Patrick Michl
Christoph Springfeld
Michael T. Dill
Targeted Oncology, 2024, 19 : 213 - 221
[4] Real-world data of durvalumab plus gemcitabine and cisplatin in patients with advanced biliary tract cancer: A Thailand multicenter observational study
Tanasanvimon, Suebpong
Maneenil, Kunlatida
Wirasorn, Kosin
Thanasombunsukh, Kijjakom
Korphaisarn, Krittiya
Sathitruangsak, Chirawadee
Wanchaijiraboon, Passakorn
Siripoon, Teerada
Teeyapan, Nattaya
Charonpongsuntorn, Chanchai
Suksombooncharoen, Thatthan
Thambamroong, Tawasapon
Laosuangkoon, Wannisa
Ngokngarm, Chavapon
Simseekeaw, Pronwasun
Akewanlop, Charuwan
Sirachainan, Ekaphop
TSCO GI Grp
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 607 - 607
[5] Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Olkus, Alexander
Tomczak, Aurelie
Berger, Anne Katrin
Rauber, Conrad
Puchas, Philip
Wehling, Cyrill
Longerich, Thomas
Mehrabi, Arianeb
Chang, De-Hua
Liermann, Jakob
Schaefer, Sophia
Pfeiffenberger, Jan
Jaeger, Dirk
Michl, Patrick
Springfeld, Christoph
Dill, Michael T.
TARGETED ONCOLOGY, 2024, 19 (02) : 213 - 221
[6] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
Rizzo, Alessandro
Salati, Massimiliano
Frega, Giorgio
Merz, Valeria
Caputo, Francesco
Di Federico, Alessandro
Palloni, Andrea
Carloni, Riccardo
Ricci, Angela Dalia
Gadaleta-Caldarola, Gennaro
Messina, Carlo
Spallanzani, Andrea
Gelsomino, Fabio
Benatti, Stefania
Luppi, Gabriele
Melisi, Davide
Dominici, Massimo
Brandi, Giovanni
MEDICINA-LITHUANIA, 2022, 58 (11):
[7] Durvalumab (DUR) effectiveness in advanced biliary tract cancer (aBTC) patients based on real-world data evidence.
Rodriguez-Pascual, Jesus
Hernandez, Gema
Ugidos, Lisardo
Parralejo, Alejandro
Rodriguez-Castano, Juan Diego
Serrano, Juan Jose
Ayuso, Angel
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 598 - 598
[8] The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: A real-world, retrospective, multicentric study
Rimini, M.
Persano, M.
Foti, S.
Fornaro, L.
Lonardi, S.
Niger, M.
Tamburini, E.
Lavacchi, D.
Rapposelli, I. G.
Martinelli, E.
Garajova, I.
Simionato, F.
Camera, S.
Rossari, F.
Amadeo, E.
Vitiello, F.
Cascinu, S.
Rimassa, L.
Antonuzzo, L.
Gardini, A. Casadei
ANNALS OF ONCOLOGY, 2023, 34 : S1528 - S1528
[9] Real-world experience supporting the role of oncologic resection and adjuvant chemotherapy in biliary tract cancers
Boutin, Melina
Krishnan, Tharani
Safro, Maria
Yang, Jenny
Jafari, Helia
Davies, Janine M.
Gill, Sharlene
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[10] Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data
Rimini, Margherita
Fornaro, Lorenzo
Lonardi, Sara
Niger, Monica
Lavacchi, Daniele
Pressiani, Tiziana
Lucchetti, Jessica
Giordano, Guido
Pretta, Andrea
Tamburini, Emiliano
Pirrone, Chiara
Rapposelli, Ilario Giovanni
Diana, Anna
Martinelli, Erika
Garajova, Ingrid
Simionato, Francesca
Schirripa, Marta
Formica, Vincenzo
Vivaldi, Caterina
Caliman, Enrico
Rizzato, Mario Domenico
Zanuso, Valentina
Nichetti, Federico
Angotti, Lorenzo
Landriscina, Matteo
Scartozzi, Mario
Ramundo, Matteo
Pastorino, Alessandro
Daniele, Bruno
Cornara, Noemi
Persano, Mara
Gusmaroli, Eleonora
Cerantola, Riccardo
Salani, Francesca
Ratti, Francesca
Aldrighetti, Luca
Cascinu, Stefano
Rimassa, Lorenza
Antonuzzo, Lorenzo
Casadei-Gardini, Andrea
LIVER INTERNATIONAL, 2023, 43 (08) : 1803 - 1812

← 1 2 3 4 5 →